<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00657969</url>
  </required_header>
  <id_info>
    <org_study_id>CADISP</org_study_id>
    <nct_id>NCT00657969</nct_id>
  </id_info>
  <brief_title>Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections</brief_title>
  <acronym>CADISP</acronym>
  <official_title>Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cervical Artery Dissections and Ischemic Stroke Patients - Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cervical Artery Dissections and Ischemic Stroke Patients - Consortium</source>
  <brief_summary>
    <textblock>
      The main purpose of this study is to look for genetic and environmental risk factors of
      cervical artery dissections, a major cause of ischemic stroke in young adults, in a large
      multicenter case-control trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Cervical artery dissections (CAD) are a major cause of ischemic stroke,
      longstanding disability, and occasionally death in young adults. Several lines of evidence
      suggest genetic predisposition for CAD. Previous genetic studies were, however, inconclusive
      mainly due to insufficient numbers of patients. Our hypothesis is that CAD is a
      multifactorial disease caused by yet largely unidentified genetic variants and environmental
      factors, which may interact.

      Aim: Our main aim is to look for genetic and environmental risk factors and gene-environment
      interactions potentially underlying CAD. In addition, therapeutic aspects are addressed in
      the setting of a multicenter registry.

      Methods: We organized a multinational European network, CADISP (Cervical Artery Dissection
      and Ischemic Stroke Patients) which targets at increasing our knowledge on the
      pathophysiological mechanisms of this disease in a large, representative patient population.
      Within this network, we are aiming to perform a de novo genetic association analysis using
      both a genome-wide and a candidate gene approach. For this purpose, 1130 patients with CAD,
      1130 patients with non-CAD ischemic stroke, and 1890 healthy controls are being recruited,
      and detailed clinical, laboratory, diagnostic, therapeutic and outcome data are being
      collected from all participating patients. We are expecting to reach the above numbers of
      subjects by the end of 2008. Analyses of the CADISP database might clarify a number of
      debated issues, including risk factors, stroke preventive treatment, and outcome predictors
      of CAD.

      We present the strategy of a collaborative project searching for genetic risk factors of
      cervical artery dissections. We hope that the CADISP network will provide detailed and novel
      data on risk factors and treatment aspects of CAD.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <completion_date type="Anticipated">September 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>association of genetic polymorphisms with cervical artery dissections</measure>
    <time_frame>2009</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>association of environmental risk factors with cervical artery dissections</measure>
    <time_frame>2009</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gene-environment interactions</measure>
    <time_frame>2009</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">4169</enrollment>
  <condition>Cervical Artery Dissection</condition>
  <condition>Stroke</condition>
  <condition>Brain Infarction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>CAD-group (Cervical Artery Dissection - group): consecutive patients with cervical artery dissection, with or without associated cerebral ischemia, hospitalized in one of the participating neurological centers; standardized inclusion and exclusion criteria apply</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>IS-group (Ischemic Stroke - Group): patients selected among consecutive patients hospitalized for an ischemic stroke without CAD, in the same centers as patients from group1, frequency-matched on age and gender with group1; standardized inclusion and exclusion criteria apply</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>HC-group (Healthy Control - Group): DNA of healthy individuals from existing DNA-databases will be used as controls for the Belgian, French, German and Swiss centers; the other centers are recruiting their own age- and sex-matched healthy controls; individuals from the 3 groups (CAD, IS and HC) are strictly matched on geographical origin in order to avoid stratification bias</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA, plasma, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        groups 1 and 2: hospital-based, neurology departments group 3: community samples
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        GROUP1:

        Inclusion Criteria:

          -  Typical radiological aspect of dissection* in a cervical artery (carotid and/or
             vertebral);* Mural hematoma, pseudoaneurysm, long tapering stenosis, intimal flap,
             double lumen, or occlusion &gt; 2 cm above the carotid bifurcation revealing a pseudo
             aneurysm or a long tapering stenosis after recanalisation

          -  Written informed consent

        Exclusion Criteria:

          -  Purely intracranial dissection

          -  Dissection occurring after an endovascular procedure

          -  Known mendelian genetic disorder that can explain the dissection (e.g. vascular
             Ehlers-Danlos syndrome)

        GROUP2:

        Inclusion Criteria:

          -  Recent ischemic stroke

          -  No signs of CAD on extracranial duplex sonography and angiography (digital subtraction
             or magnetic resonance or CT), performed &lt; 7 days after the stroke

          -  Written informed consent

        Exclusion Criteria:

          -  Possible cerebral ischemia but normal cerebral imaging

          -  CAD cannot be ruled out (e.g.persistent arterial occlusion without mural hematoma)

          -  Endovascular or surgical procedure on the coronary, cervical or cerebral arteries
             during the 48 hours preceding the cerebral infarction

          -  Cardiopathies with a very high embolic risk (Mechanical prosthetic valves, mitral
             stenosis with atrial fibrillation, intracardiac tumor, infectious endocarditis,
             myocardial infarction&lt;4 months)

          -  Arterial vasospasm following a subarachnoid haemorrhage

          -  Auto-immune disease possibly responsible for the cerebral infarction

          -  Known monogenic disease responsible for the cerebral infarction

        GROUP3:

        Inclusion criteria:

          -  Individuals from the general population without history of stroke, dissections in any
             artery, transient ischemic attack, coronary artery disease, peripheral artery disease

          -  Written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphanie Debette, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Neurology (EA2691), University Hospital of Lille; Inserm, U744, Pasteur Institute, Lille, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Caspar Grond-Ginsbach, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Neurology, University Hospital of Heidelberg, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Didier Leys, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology (EA2691), University Hospital of Lille, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sanatorio Allende</name>
      <address>
        <city>Cordoba</city>
        <zip>5000</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Brussels (ULB)</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00290</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inserm U744 Institut Pasteur de Lille</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Sainte-Anne</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Center, Schmieder-Klinik</name>
      <address>
        <city>Heidelberg</city>
        <zip>62120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Hospital of Ludwigshafen</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Munich</name>
      <address>
        <city>Munich</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Ospedale Maggiore Policlinico di Milano</name>
      <address>
        <city>Milano</city>
        <zip>20100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Milano San Raffaele</name>
      <address>
        <city>Milano</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital Milano-Bicocca</name>
      <address>
        <city>Monza</city>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Perugia</name>
      <address>
        <city>Perugia</city>
        <zip>06081</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rehabilitation Center, IRCCS Santa Lucia, Roma</name>
      <address>
        <city>Rome</city>
        <zip>00100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, University Hospital of Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neurology, Cerrahpasa Medical Faculty, Istanbul University</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Neuroscience, St George's University Hospital of London</name>
      <address>
        <city>London</city>
        <zip>SW170RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Belgium</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>Turkey</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Engelter ST, Brandt T, Debette S, Caso V, Lichy C, Pezzini A, Abboud S, Bersano A, Dittrich R, Grond-Ginsbach C, Hausser I, Kloss M, Grau AJ, Tatlisumak T, Leys D, Lyrer PA; Cervical Artery Dissection in Ischemic Stroke Patients (CADISP) Study Group. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke. 2007 Sep;38(9):2605-11. Epub 2007 Jul 26. Review.</citation>
    <PMID>17656656</PMID>
  </reference>
  <reference>
    <citation>Debette S, Metso TM, Pezzini A, Engelter ST, Leys D, Lyrer P, Metso AJ, Brandt T, Kloss M, Lichy C, Hausser I, Touzé E, Markus HS, Abboud S, Caso V, Bersano A, Grau A, Altintas A, Amouyel P, Tatlisumak T, Dallongeville J, Grond-Ginsbach C; CADISP-group. CADISP-genetics: an International project searching for genetic risk factors of cervical artery dissections. Int J Stroke. 2009 Jun;4(3):224-30. doi: 10.1111/j.1747-4949.2009.00281.x.</citation>
    <PMID>19659826</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2008</study_first_submitted>
  <study_first_submitted_qc>April 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2008</study_first_posted>
  <last_update_submitted>October 20, 2009</last_update_submitted>
  <last_update_submitted_qc>October 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. S Debette, Dr. C Grond-Ginsbach, Pr. D Leys</name_title>
    <organization>University Hospitals of Heidelberg and Lille</organization>
  </responsible_party>
  <keyword>Polymorphism, genetic</keyword>
  <keyword>Risk factors</keyword>
  <keyword>Carotid Artery, Internal, Dissection</keyword>
  <keyword>Vertebral Artery Dissection</keyword>
  <keyword>Genetic predisposition</keyword>
  <keyword>Outcome</keyword>
  <keyword>Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Brain Infarction</mesh_term>
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

